-
Sinocelltech’s Herpes Zoster Vaccine SCTV04C Clears NMPA for Clinical Trial
•
Sinocelltech Group Ltd (SHA: 688520), a biopharmaceutical company based in China, has received approval from the National Medical Products Administration (NMPA) to commence clinical trials for SCTV04C, its proprietary recombinant herpes zoster vaccine. Herpes zoster, commonly known as shingles, is an infectious skin condition that results from the reactivation of…
-
Voyager Therapeutics Secures Licensing Deal with Novartis for Gene Therapy Capsid
•
Voyager Therapeutics Inc. (NASDAQ: VYGR), a U.S.-based biotechnology company, has announced a licensing agreement with Swiss pharmaceutical giant Novartis AG (NYSE: NVS). This agreement provides Novartis with access to a novel capsid from Voyager’s TRACER capsid discovery platform for its gene therapy program targeting an undisclosed rare neurologic disease. Under…
-
Jiangsu Kanion Pharmaceutical Gets NMPA Go-Ahead for Psoriasis Drug Clinical Trial
•
Jiangsu Kanion Pharmaceutical Co., Ltd (SHA: 600557), a prominent pharmaceutical company based in China, has announced that it has received approval from the National Medical Products Administration (NMPA) to commence clinical studies for its investigational drug KYS202004A for the treatment of psoriasis. This Category 1 biologic is a novel, dual-targeted…
-
Genesis MedTech Secures NMPA Approval for Innovative Surgical Energy Products
•
Genesis MedTech, a leading medical device company headquartered in Singapore, has secured marketing approvals from China’s National Medical Products Administration (NMPA) for two of its high-frequency electrosurgical energy products: the “OP9 ultrasonic high frequency integrated surgical equipment” and the “disposable cutting and closing knife head.” The OP9 device is a…
-
True Health’s Advanced Microwave Ablation System Gains NMPA Nod for Liver Tumor Treatment
•
True Health (Guangdong Hengqin) Medical Technology Co., Ltd has received marketing approval from China’s National Medical Products Administration (NMPA) for its innovative navigation positioning microwave ablation system. This advanced medical device utilizes CT images to devise a precise needle insertion plan prior to surgery and provides real-time guidance for the…
-
Venus Medtech Initiates Global Study with Venus Vitae TAVR System Implantations
•
Venus Medtech (Hangzhou) Inc., listed on the Hong Kong Stock Exchange as HKG: 2500, has reached a significant milestone with the implantation of its next-generation transcatheter aortic valve replacement (TAVR) system, Venus Vitae, in two patients as part of the global, multi-center pivotal SMART-ALIGN study. This prospective, randomized, interventional study…
-
China’s Hainan Free Trade Port Implements ‘Zero Tax’ on Medical Imports for Designated Entities
•
In a joint effort to bolster healthcare services, China’s Ministry of Finance, National Health Commission (NHC), General Administration of Customs, State Taxation Administration, and National Medical Products Administration (NMPA) have announced a “zero tax” policy on drugs and medical devices imported through the Hainan Free Trade Port. The initiative targets…
